Clinical trials show that it improves fine lines, hyperpigmentation, and skin appearance
Formulation factors influencing injection site reactions include preservative content, solution characteristics, and injection volume
TRIUMPH-3 (NCT05882045) Design: Phase 3, 80-week, randomised, double-blind, placebo-controlled trial in adults with severe obesity (Class 2 or 3, BMI 35) and established cardiovascular disease, with or without type 2 diabetes
Always keep the vial in a dark, cool place, preferably inside its original packaging or in the refrigerator, where it is protected from light
In this regard, we found elevations in plasma FGF21 from 12 up to 72 h post-G49 injection